Vascular Biogenics Q2 EPS $(0.01) Up From $(0.12) YoY
Portfolio Pulse from Happy Mohamed
Vascular Biogenics (NASDAQ:VBLT) reported Q2 losses of $(0.01) per share, a 91.67% increase over losses of $(0.12) per share from the same period last year.
August 14, 2023 | 12:24 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Vascular Biogenics reported a significant improvement in its Q2 losses compared to the same period last year.
Vascular Biogenics reported a significant improvement in its Q2 losses, which is a positive signal for investors. This could potentially lead to a positive impact on the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100